141 related articles for article (PubMed ID: 8899801)
1. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801
[TBL] [Abstract][Full Text] [Related]
2. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas.
Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS
Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
5. Gastrin receptor expression during azaserine-induced rat pancreatic carcinogenesis.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
J Surg Res; 1996 Jun; 63(1):105-9. PubMed ID: 8661181
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma.
Zhou W; Povoski SP; Bell RH
Carcinogenesis; 1993 Oct; 14(10):2189-92. PubMed ID: 8222074
[TBL] [Abstract][Full Text] [Related]
7. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
8. Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat.
Hajri A; Damgé C
Pharm Res; 1998 Nov; 15(11):1767-74. PubMed ID: 9834001
[TBL] [Abstract][Full Text] [Related]
9. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
10. Growth of azaserine-induced putative preneoplastic nodules in the rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Ann N Y Acad Sci; 1994 Mar; 713():439-41. PubMed ID: 8018216
[No Abstract] [Full Text] [Related]
11. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
[TBL] [Abstract][Full Text] [Related]
12. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
Lhoste EF; Roebuck BD; Longnecker DS
Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
[TBL] [Abstract][Full Text] [Related]
14. Gut peptide receptors in pancreata of azaserine-treated and normal control rats.
Tang C; Biemond I; Appel MJ; Visser CJ; Woutersen RA; Lamers CB
Carcinogenesis; 1995 Dec; 16(12):2951-6. PubMed ID: 8603469
[TBL] [Abstract][Full Text] [Related]
15. gamma-Glutamyltransferase activity in atypical acinar cell nodules of rat pancreas.
Faribault G; Wiebkin P; Hamilton JW; Longnecker DS; Curphey TJ
Toxicol Appl Pharmacol; 1987 May; 88(3):338-45. PubMed ID: 2883739
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide.
Meijers M; Appel MJ; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Carcinogenesis; 1992 Sep; 13(9):1525-8. PubMed ID: 1394835
[TBL] [Abstract][Full Text] [Related]
17. Effect of bombesin and caerulein on early stages of carcinogenesis induced by azaserine in the rat pancreas.
Lhoste EF; Longnecker DS
Cancer Res; 1987 Jun; 47(12):3273-7. PubMed ID: 3581068
[TBL] [Abstract][Full Text] [Related]
18. Effect of orchiectomy and testosterone on the early stages of azaserine-induced pancreatic carcinogenesis in the rat.
Lhoste EF; Roebuck BD; Stern JE; Longnecker DS
Pancreas; 1987; 2(1):38-43. PubMed ID: 3494994
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8.
Karsenty L; Hajri A; Aprahamian M; Garaud JC; Doffoël M; Damgé C
Pancreas; 1993 Mar; 8(2):204-11. PubMed ID: 8460096
[TBL] [Abstract][Full Text] [Related]
20. The effect of fasting and cholecystokinin stimulation on normal and neoplastic tissue in the rat pancreas.
Daly JM; Oates PS; Morgan RG
Tissue Cell; 1992; 24(5):625-33. PubMed ID: 1279837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
